We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Teladoc (TDOC) Stock Moves -1.36%: What You Should Know
Read MoreHide Full Article
The latest trading session saw Teladoc (TDOC - Free Report) ending at $9.43, denoting a -1.36% adjustment from its last day's close. This change was narrower than the S&P 500's 1.76% loss on the day. At the same time, the Dow lost 1.48%, and the tech-heavy Nasdaq lost 2.64%.
Prior to today's trading, shares of the telehealth services provider had lost 5.91% over the past month. This has lagged the Medical sector's gain of 1.11% and the S&P 500's loss of 1.26% in that time.
Investors will be eagerly watching for the performance of Teladoc in its upcoming earnings disclosure. The company is expected to report EPS of -$0.34, up 30.61% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $617.45 million, indicating a 4.44% decrease compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates project earnings of -$0.94 per share and a revenue of $2.51 billion, demonstrating changes of +83.99% and -2.32%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for Teladoc. These revisions help to show the ever-changing nature of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 4.92% higher. Teladoc is holding a Zacks Rank of #3 (Hold) right now.
The Medical Services industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 83, placing it within the top 34% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Teladoc (TDOC) Stock Moves -1.36%: What You Should Know
The latest trading session saw Teladoc (TDOC - Free Report) ending at $9.43, denoting a -1.36% adjustment from its last day's close. This change was narrower than the S&P 500's 1.76% loss on the day. At the same time, the Dow lost 1.48%, and the tech-heavy Nasdaq lost 2.64%.
Prior to today's trading, shares of the telehealth services provider had lost 5.91% over the past month. This has lagged the Medical sector's gain of 1.11% and the S&P 500's loss of 1.26% in that time.
Investors will be eagerly watching for the performance of Teladoc in its upcoming earnings disclosure. The company is expected to report EPS of -$0.34, up 30.61% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $617.45 million, indicating a 4.44% decrease compared to the same quarter of the previous year.
For the full year, the Zacks Consensus Estimates project earnings of -$0.94 per share and a revenue of $2.51 billion, demonstrating changes of +83.99% and -2.32%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for Teladoc. These revisions help to show the ever-changing nature of near-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 4.92% higher. Teladoc is holding a Zacks Rank of #3 (Hold) right now.
The Medical Services industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 83, placing it within the top 34% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.